Clinical Trial Update: A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing verteporfin PDT plus intravitreal triamcinolone versus verteporfin PDT plus intravitreal pegaptanib for age-related macular degenerati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Kenalog (triamcinolone acetonide)
• Macugen (pegaptanib sodium)
• Visudyne (verteporfin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Macular Degeneration, Choroidal Neovascularization | Phase 3 | Status: COMPLETED | Results posted: 2011-05-02